Current Fungal Infection Reports

Top Research Topics at Current Fungal Infection Reports?

Current Fungal Infection Reports explores disciplines such as Intensive care medicine, Immunology, Microbiology, Antifungal and Disease. In addition to Intensive care medicine research, the journal aims to explore topics under Amphotericin B, Epidemiology, Fluconazole, Voriconazole and Aspergillosis. Topics in Epidemiology were tackled in line with various other fields like Incidence (epidemiology), Transplantation and Environmental health.

The study on Voriconazole presented in it intersects with subjects under the field of Itraconazole. The concepts on Aspergillosis presented in it can also apply to other research fields, including Mucormycosis and Internal medicine. The journal features Immunology research that overlaps with concepts in Acquired immunodeficiency syndrome (AIDS).

Current Fungal Infection Reports focuses on Microbiology research which is adjacent to topics in Virulence. Issues in Antifungal were discussed, taking into consideration concepts from other disciplines like Susceptibility testing and Bioinformatics. It addresses concerns in Disease which are intertwined with other disciplines, such as Dermatology and Histoplasmosis.

• Intensive care medicine (35.88%)
• Immunology (22.47%)
• Microbiology (20.41%)

What are the most cited papers published in the journal?

• Current Thoughts in Fungal Keratitis: Diagnosis and Treatment (124 citations)
• Therapeutic Drug Monitoring of Posaconazole: an Update (87 citations)
• Epidemiology of Invasive Fungal Infections in Latin America (68 citations)

Research areas of the most cited articles at Current Fungal Infection Reports:

The most cited articles primarily tackle Microbiology, Immunology, Aspergillosis, Intensive care medicine and Aspergillus. While the most cited articles focused on Immunology, they were also able to explore topics like Fluconazole and Chronic mucocutaneous candidiasis. The works on Intensive care medicine tackled in the published papers bring together disciplines like Itraconazole, Voriconazole and Surgery.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Cancer

The previous edition focused in particular on these issues:

The journal facilitates discussions on Intensive care medicine, Epidemiology, Computational biology, Antifungal and Disease. The work on Intensive care medicine tackled in it brings together disciplines like Lung, Review article and Medical diagnosis. The journal facilitates discussions on Epidemiology that incorporate concepts from other fields like Allogeneic hsct, Disease management (health) and Scedosporium, Lomentospora.

It explores research in Drug resistance and overlapping concepts in Echinocandins, Antifungal drugs, INVESTIGATIONAL AGENTS, Bioinformatics and Clinical trial to expand the discourse in Antifungal. Some problems in Disease that were presented in it overlapped with concepts under Dermatology, Aspergillosis, Etiology and Head and neck. Many of the research works in Aspergillosis, specifically Invasive fungal disease, closely connected to disciplines like In patient.

The most cited articles from the last journal are:

• Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory (2 citations)
• Investigational Agents for the Treatment of Resistant Yeasts and Molds. (2 citations)
• Cutaneous Aspergillosis in Children and Adolescents (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Current Fungal Infection Reports (based on the number of publications) are:

• Alexandro Bonifaz (16 papers) published 1 paper at the last edition the same number as at the previous edition,
• Emmanuel Roilides (11 papers) absent at the last edition,
• Tom Chiller (10 papers) absent at the last edition,
• Michael A. Pfaller (8 papers) absent at the last edition,
• Nathan P. Wiederhold (8 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Fungal Infection Reports (based on the number of publications) are:

• Centers for Disease Control and Prevention (22 papers) absent at the last edition,
• Duke University (17 papers) absent at the last edition,
• Hospital General de México (13 papers) published 1 paper at the last edition the same number as at the previous edition,
• University of Texas Health Science Center at San Antonio (12 papers) absent at the last edition,
• University of Sydney (10 papers) published 3 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 0.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 31.25% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.25% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.75% of all publications and 43.75% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.